Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation

Wuhan Hui1, Wei Zhang1, Congyan Liu1

  • 1Department of Hematology, Xuan Wu Hospital, Capital Medical University, Beijing, People's Republic of China.

Abstract

Insights

Mutations in the calreticulin (CALR) gene are linked to essential thrombocythemia (ET). This study reveals significant protein and pathway alterations in ET patients with CALR mutations, offering insights into disease mechanisms.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Calreticulin (CALR) gene mutations are observed in essential thrombocythemia (ET).
  • The precise molecular mechanisms underlying CALR mutations in ET remain incompletely understood.
  • Characterizing protein expression alterations is crucial for elucidating ET pathogenesis.

Purpose of the Study:

  • To investigate protein expression changes in ET patients with CALR mutations.
  • To identify signaling pathways potentially involved in CALR-mutated ET.
  • To compare molecular profiles between CALR-mutated ET and JAK2-mutated ET.

Main Methods:

  • Protein pathway array analysis was conducted on neutrophils.
  • Study included 18 ET patients with CALR mutations, 20 ET patients with JAK2 mutations, and 20 healthy controls.
  • Ingenuity Pathway Analysis (IPA) was used for network and pathway analysis.

Main Results:

  • Twenty proteins were differentially expressed in CALR-mutated ET compared to controls, linked to cancer pathways.
  • Apoptotic and cellular cytokine pathways were identified as potentially participating in CALR-mutated ET pathogenesis.
  • Eight proteins showed differential dysregulation between CALR-mutated ET and JAK2-mutated ET, suggesting distinct signaling.

Conclusions:

  • Significant alterations in signaling proteins and pathways are evident in ET patients with CALR mutations.
  • These findings contribute to a deeper understanding of the pathological mechanisms in ET.
  • The study highlights potential differences in signaling pathways activated by CALR versus JAK2 mutations.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K